Review article: Renal support in critical illness
نویسندگان
چکیده
منابع مشابه
Nutritional support in critical illness.
Critically ill patients, almost by definition, are catabolic and often hypermetabolic. Although it is generally accepted that such patients would benefit from nutritional support, there are remarkably little data to support this premise. Several experts believe that prospective, randomized, controlled studies to document the efficacy of nutrition support in improving outcome in critically ill p...
متن کاملRenal effects of critical illness
Acute renal failure (ARF) is broadly defined as deterioration of renal function over days to weeks, a common occurrence in intensive care unit (ICU) patients; incidence and mortality estimates vary according to ARF definition and associated morbidities.'-"he mortality of ARF is 50-80% in ICU populations, and has not declined significantly since the initial marked benefit of acute dialysis thera...
متن کاملNutrition support in critical illness: amino acids.
The general approach to the nutritional care of the catabolic, malnourished or critically ill patient involves delivery of a balanced diet including energy (in the form of carbohydrates and lipids), an adequate amount of nitrogen, all essential nutrients (amino acids, fatty acids, vitamins, electrolytes) and fluid [1]. Traditionally, the qualitative and quantitative composition of dietetic meas...
متن کاملScience review: Natriuretic peptides in critical illness
The present review will cover the mechanisms of release and the potential pathophysiological role of different natriuretic peptides in critically ill patients. By focusing on the cardiovascular system, possible implications of natriuretic peptides for diagnosis and treatment will be presented. In critical illness such as sepsis, trauma or major surgery, systemic hypotension and an intrinsic myo...
متن کاملLevosimendan in Critical Illness: A Literature Review
Levosimendan, the active enantiomer of simendan, is a calcium sensitizer developed for treatment of decompensated heart failure, exerts its effects independently of the beta adrenergic receptor and seems beneficial in cases of severe, intractable heart failure. Levosimendan is usually administered as 24-h infusion, with or without a loading dose, but dosing needs adjustment in patients with sev...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Canadian Journal of Anesthesia/Journal canadien d'anesthésie
سال: 2010
ISSN: 0832-610X,1496-8975
DOI: 10.1007/s12630-010-9376-3